Yatendra Mulpuri

Yatendra Mulpuri

Auto-generated profile, based on publicly available information

Yatendra Mulpuri

Department of Molecular Pathobiology, College of Dentistry, New York University; New York

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HSHerbert H. Seltzman
Herbert H. Seltzman
CSCraig Shiner
Craig Shiner
EHErin E. Hirt
Erin E. Hirt
AGAnne F. Gilliam
Anne F. Gilliam
BTBrian F. Thomas
Brian F. Thomas
ISIgor Spigelman
Igor Spigelman

1 September 2018 in Neuropharmacology
Verified
Journal Article
Closed access
YMYatendra Mulpuri
Yatendra Mulpuri
VMVincent N. Marty
Vincent N. Marty
JMJoseph J. Munier
Joseph J. Munier
KMKen Mackie
Ken Mackie
BSBrian L. Schmidt
Brian L. Schmidt
ISIgor Spigelman
Igor Spigelman

1 November 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Supanigar RuangsriSupanigar Ruangsri
Supanigar Ruangsri
ALAudrey Lin
Audrey Lin
YMYatendra Mulpuri
Yatendra Mulpuri
KLKyung Lee
Kyung Lee
ISIgor Spigelman
Igor Spigelman
INIchiro Nishimura
Ichiro Nishimura
Painful peripheral neuropathy is a significant clinical problem; however, its pathological mechanism and effective treatments remain elusive. Increased peripheral expression of tetrodotoxin-resistant voltage-gated sodium channel 1.8 (NaV1.8) has been shown to associate with chronic pain symptoms in humans and experimental animals. Sciatic nerve entrapment (SNE) injury was used to develop neuropathic pain symptoms in rats, resulting in increased NaV1.8 mRNA in the injured nerve but not in dorsal root ganglia (DRG). To study the role of NaV1.8 mRNA in the pathogenesis of SNE-induced painful neuropathy, NaV1.8 shRNA vector was delivered by subcutaneous injection of cationized gelatin/plasmid DNA polyplex into the rat hindpaw and its subsequent retrograde transport via sciatic nerve to DRG. This in vivo NaV1.8 shRNA treatment reversibly and repeatedly attenuated the SNE-induced pain symptoms, an effect that became apparent following a distinct lag period of 3–4 days and lasted for 4–6 days before returning to pretreatment levels. Surprisingly, apparent knockdown of NaV1.8 mRNA occurred only in the injured nerve, not in the DRG, during the pain alleviation period. Levels of heteronuclear NaV1.8 RNA were unaffected by SNE or shRNA treatments, suggesting that transcription of the Scn10a gene encoding NaV1.8 was unchanged. Based on these data, we postulate that increased axonal mRNA transport results in accumulation of functional NaV1.8 protein in the injured nerve and the development of painful neuropathy symptoms. Thus, targeted delivery of agents that interfere with axonal NaV1.8 mRNA may represent effective neuropathic pain treatments.

13 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
THTakashi Hirai
Takashi Hirai
YMYatendra Mulpuri
Yatendra Mulpuri
YCYanbing Cheng
Yanbing Cheng
ZXZheng Xia
Zheng Xia
WLWei Li
Wei Li
INIchiro Nishimura
Ichiro Nishimura
Neuronal cells express considerable plasticity responding to environmental cues, in part, through subcellular mRNA regulation. Here we report on the extensive changes in distribution of mRNAs in the cell body and axon compartments of peripheral sensory neurons and the 3′ untranslated region (3′UTR) landscapes after unilateral sciatic nerve entrapment (SNE) injury in rats. Neuronal cells dissociated from SNE-injured and contralateral L4 and L5 dorsal root ganglia were cultured in a compartmentalized system. Axonal and cell body RNA samples were separately subjected to high throughput RNA sequencing (RNA-Seq). The injured axons exhibited enrichment of mRNAs related to protein synthesis and nerve regeneration. Lengthening of 3′UTRs was more prevalent in the injured axons, including the newly discovered alternative cleavage and polyadenylation of NaV1.8 mRNA. Alternative polyadenylation was largely independent from the relative abundance of axonal mRNAs; but they were highly clustered in functional pathways related to RNA granule formation in the injured axons. These RNA-Seq data analyses indicate that peripheral nerve injury may result in highly selective mRNA enrichment in the affected axons with 3′UTR alterations potentially contributing to the mechanism of neuropathic pain.

1 July 2014 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
JLJing Liang
Jing Liang
VMVincent N. Marty
Vincent N. Marty
YMYatendra Mulpuri
Yatendra Mulpuri
RORichard W. Olsen
Richard W. Olsen
ISIgor Spigelman
Igor Spigelman
The nucleus accumbens (NAcc) is a key structure of the mesolimbic dopaminergic reward system and plays an important role in mediating alcohol-seeking behaviors. Alterations in glutamatergic and GABAergic signaling were recently demonstrated in the NAcc of rats after chronic intermittent ethanol (CIE) treatment, a model of alcohol dependence. Here we studied dopamine (DA) modulation of GABAergic signaling and how this modulation might be altered by CIE treatment. We show that the tonic current ( Itonic) mediated by extrasynaptic γ-aminobutyric acid type A receptors (GABAARs) of medium spiny neurons (MSNs) in the NAcc core is differentially modulated by DA at concentrations in the range of those measured in vivo (0.01–1 μM), without affecting the postsynaptic kinetics of miniature inhibitory postsynaptic currents (mIPSCs). Use of selective D1 receptor (D1R) and D2 receptor (D2R) ligands revealed that Itonicpotentiation by DA (10 nM) is mediated by D1Rs while Itonicdepression by DA (0.03–1 μM) is mediated by D2Rs in the same MSNs. Addition of guanosine 5′- O-(2-thiodiphosphate) (GDPβS) to the recording pipettes eliminated Itonicdecrease by the selective D2R agonist quinpirole (5 nM), leaving intact the quinpirole effect on mIPSC frequency. Recordings from CIE and vehicle control (CIV) MSNs during application of D1R agonist (SKF 38393, 100 nM) or D2R agonist (quinpirole, 2 nM) revealed that SKF 38393 potentiated Itonicto the same extent, while quinpirole reduced Itonicto a similar extent, in both groups of rats. Our data suggest that the selective modulatory effects of DA on Itonicare unaltered by CIE treatment and withdrawal.

16 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMarkus Lakemeyer
Markus Lakemeyer
RLRocco Latorre
Rocco Latorre
KBKristyna Blazkova
Kristyna Blazkova
DJDane D Jensen
Dane D Jensen
HWHannah M. Wood
Hannah M. Wood
MBMatthew Bogyo
Matthew Bogyo
Protease-activated receptor 2 (PAR2) is a central regulator of intestinal barrier function, inflammation and pain. Upregulated intestinal proteolysis and PAR2-signaling are implicated in inflammatory bowel diseases (IBDs) and irritable bowel syndrome (IBS). To identify potential bacterial regulators of PAR2 activity, we developed a functional assay for PAR2 processing and used it to screen conditioned media from a library of diverse gut commensal microbes. We found that multiple bacteria secrete proteases that cleave host PAR2. Using chemoproteomic profiling with a covalent irreversible inhibitor, we identified a previously uncharacterized Bacteroides fragilis serine protease Bfp1, and showed that it cleaves and activates PAR2 in multicellular and murine models. PAR2 cleavage by Bfp1 disrupts the intestinal barrier, sensitizes nociceptors, and triggers colonic inflammation and abdominal pain. Collectively, our findings uncover Bfp1-mediated PAR2-processing as a new axis of host-commensal-interaction in the gut that has the potential to be targeted for therapeutic intervention in IBD or IBS.